Chemical Structure : UNC2025
CAS No.: 1429881-91-3
货号: PC-42993Not For Human Use, Lab Use Only.
UNC2025 is a potent, orally bioavailable Mer/FLT3 dual inhibitor with IC50 of 0.74/0.8 nM, 700-fold less active against Met compared to Mer.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥1180 | In stock | |
25 mg | ¥1980 | In stock | |
50 mg | ¥3480 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
UNC2025 is a potent, orally bioavailable Mer/FLT3 dual inhibitor with IC50 of 0.74/0.8 nM, 700-fold less active against Met compared to Mer.
UNC2025 also potently inhibits Axl and Tyro3 (IC50=14 and 17 nM) in vitro.
UNC2025 inhibits Mer phosphorylation (IC50=2.7 nM) in 697 B-ALL cells, decreases phosphorylation of Flt3 (IC50=14 nM) in Flt3-ITD positive Molm-14 AML cells.
UNC2025 effectively inhibits phosphorylation of Axl (IC50=122 nM) and Tyro3 (IC50=301 nM), 40- to 100-fold selectivity for Mer over Axl and Tyro3.
UNC2025 inhibits Mer phosphorylation in bone marrow leukemia cells in vivo.
分子量 | 476.6568 | |
分子式 | C28H40N6O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: 33.33 mg/mL; H2O: < 4.9 mg/mL |
|
Chemical Name/SMILES |
Cyclohexanol, 4-[2-(butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-, trans- |
1. Zhang W, et al. J Med Chem. 2014 Aug 28;57(16):7031-41.
2. Cummings CT, et al. Mol Cancer Ther. 2015 Sep;14(9):2014-22.
3. DeRyckere D, et al. Clin Cancer Res. 2017 Mar 15;23(6):1481-1492.
4. Branchford BR, et al. J Thromb Haemost. 2018 Feb;16(2):352-363.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright